{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:00:25Z","timestamp":1790805625352,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xphs.2026.104435","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:14:23Z","timestamp":1784906063000},"page":"104435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of ultraviolet irradiation of pharmaceutical excipients in mitigating N-nitrosamine generation"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1277-6416","authenticated-orcid":false,"given":"Saki","family":"Minamioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8875-3755","authenticated-orcid":false,"given":"Shun","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3918-7824","authenticated-orcid":false,"given":"Naoki","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.xphs.2026.104435_bib0001","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acs.oprd.0c00323","article-title":"Pathways for N-nitroso compound formation: secondary amines and beyond","volume":"24","author":"L\u00f3pez-Rodr\u00edguez","year":"2020","journal-title":"Org Process Res Dev"},{"issue":"6","key":"10.1016\/j.xphs.2026.104435_bib0002","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1021\/acs.oprd.5c00097","article-title":"Drug substance and drug product workflows for quality risk management for the presence of nitrosamines in medicines","volume":"29","author":"Dirat","year":"2025","journal-title":"Org Process Res Dev"},{"issue":"10","key":"10.1016\/j.xphs.2026.104435_bib0003","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/acs.oprd.3c00100","article-title":"The nitrosamine \u201csaga\u201d: lessons learned from five years of scrutiny","volume":"27","author":"Nudelman","year":"2023","journal-title":"Org Process Res Dev"},{"issue":"1","key":"10.1016\/j.xphs.2026.104435_bib0004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bjc.1956.15","article-title":"The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine","volume":"10","author":"Magee","year":"1956","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.xphs.2026.104435_bib0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.xphs.2023.01.027","article-title":"N-nitrosamine formation in pharmaceutical solid drug products: experimental observations","volume":"112","author":"Moser","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104435_bib0006","unstructured":"EMA. European medicines regulatory network\u2019s response to nitrosamine impurities in human medicines; 2025. https:\/\/www.ema.europa.eu\/en\/documents\/report\/report-european-medicines-regulatory-networks-response-nitrosamine-impurities-human-medicines_en.pdf. Accessed March 20, 2026."},{"key":"10.1016\/j.xphs.2026.104435_bib0007","unstructured":"FDA. Recommended acceptable intake limits for nitrosamine drug substance-related impurities (NDSRIs) guidance for industry; 2023. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/recommended-acceptable-intake-limits-nitrosamine-drug-substance-related-impurities. Accessed April 5, 2026."},{"key":"10.1016\/j.xphs.2026.104435_bib0008","unstructured":"FDA. Pfizer expands voluntary nationwide recall to include all lots of CHANTIX\u00ae (varenicline) tablets due to n-nitroso varenicline content; 2021. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/pfizer-expands-voluntary-nationwide-recall-include-all-lots-chantixr-varenicline-tablets-due-n. Accessed March 20, 2026."},{"key":"10.1016\/j.xphs.2026.104435_bib0009","unstructured":"ICH. M7(R2) assessment and control of dna reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk; 2023. https:\/\/database.ich.org\/sites\/default\/files\/ICH_M728R229_Guideline_Step4_2023_0216_0.pdf. Accessed March 21, 2026."},{"key":"10.1016\/j.xphs.2026.104435_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105672","article-title":"Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine","volume":"152","author":"Jolly","year":"2024","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104435_bib0011","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.xphs.2022.12.022","article-title":"Regulatory experiences with root causes and risk factors for nitrosamine impurities in pharmaceuticals","volume":"112","author":"Horne","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104435_bib0012","series-title":"Nitrosamine Impurities: Guidance for Marketing Authorisation Holders","year":"2024"},{"issue":"5","key":"10.1016\/j.xphs.2026.104435_bib0013","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.xphs.2022.11.013","article-title":"The landscape of potential small and drug substance related nitrosamines in pharmaceuticals","volume":"112","author":"Schlingemann","year":"2023","journal-title":"J Pharm Sci"},{"issue":"23","key":"10.1016\/j.xphs.2026.104435_bib0014","doi-asserted-by":"crossref","first-page":"11857","DOI":"10.1021\/acs.chemrev.9b00383","article-title":"Reductive amination in the synthesis of pharmaceuticals","volume":"119","author":"Afanasyev","year":"2019","journal-title":"Chem Rev"},{"issue":"37","key":"10.1016\/j.xphs.2026.104435_bib0015","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1016\/S0040-4020(01)00722-0","article-title":"Synthesis of secondary amines","volume":"57","author":"Salvatore","year":"2001","journal-title":"Tetrahedron"},{"issue":"9","key":"10.1016\/j.xphs.2026.104435_bib0016","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1021\/acs.oprd.0c00224","article-title":"Potential for the formation of N-nitrosamines during the manufacture of active pharmaceutical ingredients: an assessment of the risk posed by trace nitrite in water","volume":"24","author":"Ashworth","year":"2020","journal-title":"Org Process Res Dev"},{"issue":"6","key":"10.1016\/j.xphs.2026.104435_bib0017","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.xphs.2022.04.016","article-title":"A nitrite excipient database: a useful tool to support N-nitrosamine risk assessments for drug products","volume":"112","author":"Boetzel","year":"2023","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2026.104435_bib0018","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1021\/acs.oprd.3c00274","article-title":"N-Nitrosodimethylamine formation in metformin drug products by the reaction of dimethylamine and atmospheric NO 2","volume":"27","author":"Fukuda","year":"2023","journal-title":"Org Process Res Dev"},{"issue":"3","key":"10.1016\/j.xphs.2026.104435_bib0019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00312290","article-title":"Kinetic studies on the formation of nitrosamines I. Formation of dimethylnitrosamine in aqeous solution of perchloric acid","volume":"91","author":"Cachaza","year":"1978","journal-title":"Z Krebsforsch Klin Onkol Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104435_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/acs.oprd.4c00301","article-title":"Exploration for chemical filter cartridges that can reduce nitrogen oxides, a common factor in the formation of nitrosamines","volume":"29","author":"Nomura","year":"2025","journal-title":"Org Process Res Dev"},{"issue":"10","key":"10.1016\/j.xphs.2026.104435_bib0021","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/acs.oprd.3c00153","article-title":"Formation of N-nitrosamine drug substance related impurities in medicines: a regulatory perspective on risk factors and mitigation strategies","volume":"27","author":"Cioc","year":"2023","journal-title":"Org Process Res Dev"},{"issue":"12","key":"10.1016\/j.xphs.2026.104435_bib0022","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.xphs.2021.08.010","article-title":"Inhibition of N-nitrosamine formation in drug products: a model study","volume":"110","author":"Nanda","year":"2021","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2026.104435_bib0023","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.xphs.2023.06.013","article-title":"Bumetanide as a model NDSRI substrate: N-nitrosobumetanide impurity formation and its inhibition in bumetanide tablets","volume":"112","author":"Shakleya","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104435_bib0024","article-title":"Tablets: drug interview form","author":"Januvia","year":"2025","journal-title":"MSD Connect"},{"issue":"4","key":"10.1016\/j.xphs.2026.104435_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2026.104190","article-title":"Advantages and limitations of the inclusion of ascorbic acid on nitrosamine mitigation in pharmaceutical drug products","volume":"115","author":"Mekhdjian","year":"2026","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2026.104435_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.104007","article-title":"Monitoring the concentration of nitrogen oxides in the fluidized bed drying\/granulation process and evaluation of reduction methods","volume":"114","author":"Kodama","year":"2025","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104435_bib0027","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1021\/acs.oprd.5c00182","article-title":"Three-pronged approach (active pharmaceutical ingredients, excipients, and NOx-free air) successfully suppressed the formation of nitroso-atomoxetine to 0.097 ppm","volume":"29","author":"Nomura","year":"2025","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2026.104435_bib0028","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.scitotenv.2017.04.238","article-title":"Challenges in photocatalytic reduction of nitrate as a water treatment technology","volume":"599-600","author":"Tugaoen","year":"2017","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.xphs.2026.104435_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.uclim.2023.101457","article-title":"NOx emissions by real-world fresh and old asphalt mixtures: impact of temperature, relative humidity, and UV-irradiation","volume":"49","author":"Lasne","year":"2023","journal-title":"Urban Clim"},{"key":"10.1016\/j.xphs.2026.104435_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126212","article-title":"Construction of a modified Arrhenius equation for predicting drug nitrosation in solid dosage form","volume":"685","author":"Takegawa","year":"2025","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2026.104435_bib0031","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acs.oprd.2c00402","article-title":"Quantitation of reactive nitrosating agents in pharmaceutical excipients for N-nitrosamine risk assessments","volume":"27","author":"Yamamoto","year":"2023","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2026.104435_bib0032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-9790-9_2","article-title":"Methods for measuring nitrate reductase, nitrite levels, and nitric oxide from plant tissues","volume":"2057","author":"Wany","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104435_bib0033","first-page":"3098","article-title":"Microcrystalline cellulose in pharmaceutical formulations: a comprehensive review on applications, concentrations, and functional attributes","volume":"3","author":"Janvalkar","year":"2025","journal-title":"Int J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104435_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103778","article-title":"Using response surface methodology to quantify iron oxide levels needed to protect photolabile active pharmaceutical ingredients in oral solid dosage forms","volume":"114","author":"Kawakita","year":"2025","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104435_bib0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0167-4838(00)00233-8","article-title":"Engineering of cyclodextrin glycosyltransferase reaction and product specificity","volume":"1543","author":"van der Veen","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.xphs.2026.104435_bib0036","article-title":"Facile preparation and characterization of biodegradable and biocompatible UV shielding transdermal patches based on natural rubber latex- dextrin blends","volume":"277","author":"Mathew","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2026.104435_bib0037","article-title":"Involvement of inorganic nitrogen species","volume":"963","author":"Duan","year":"2025","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.xphs.2026.104435_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclepro.2020.123065","article-title":"Mini review on the roles of nitrate\/nitrite in advanced oxidation processes: radicals transformation and products formation","volume":"273","author":"Wu","year":"2020","journal-title":"J Cleaner Prod"},{"issue":"2","key":"10.1016\/j.xphs.2026.104435_bib0039","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/pharmaceutics14020325","article-title":"Oxidation of drugs during drug product development: problems and solutions","volume":"14","author":"Gabri\u010d","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2026.104435_bib0040","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","article-title":"Reactive impurities in excipients: profiling, identification and mitigation of drug\u2013excipient incompatibility","volume":"12","author":"Wu","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2026.104435_bib0041","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3109\/03639045.2015.1078349","article-title":"Statistical comparison of dissolution profiles","volume":"42","author":"Wang","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2026.104435_bib0043","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.polymdegradstab.2009.08.007","article-title":"Photooxidation of poly(N-vinylpyrrolidone) (PVP) in the solid state and in aqueous solution","volume":"94","author":"Hassouna","year":"2009","journal-title":"Polym Degrad Stab"},{"issue":"1","key":"10.1016\/j.xphs.2026.104435_bib0044","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.polymdegradstab.2005.01.003","article-title":"Photo-induced degradation of cellulose","volume":"89","author":"Male\u0161i\u010d","year":"2005","journal-title":"Polym Degrad Stab"},{"key":"10.1016\/j.xphs.2026.104435_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsolstr.2024.113086","article-title":"Investigating the influence of stress on UV-induced degradation in cellulose acetate: a comprehensive experimental characterization","volume":"305","author":"Alkhoury","year":"2024","journal-title":"Int J Solids Struct"},{"issue":"2","key":"10.1016\/j.xphs.2026.104435_bib0046","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/jf0010174","article-title":"Photodegradation of cassava and corn starches","volume":"49","author":"Bertolini","year":"2001","journal-title":"J Agric Food Chem"},{"issue":"9","key":"10.1016\/j.xphs.2026.104435_bib0047","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.3390\/ijms24098159","article-title":"Phototoxic or photoprotective?\u2014advances and limitations of titanium(IV) oxide in dermal formulations\u2014a review","volume":"24","author":"Gackowski","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104435_bib0048","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.xphs.2024.06.021","article-title":"Near UV light photo-degradation of lactate and related \u03b1-hydroxycarboxylates in the presence of Fe(III): formation of carbon dioxide radical anion","volume":"113","author":"Zhang","year":"2024","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:25:25Z","timestamp":1790803525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926002844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022354926002844"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104435","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of ultraviolet irradiation of pharmaceutical excipients in mitigating N-nitrosamine generation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104435"}}